WELCOME TO THE HOMEPAGE OF THE MULTIPLE SCLEROSIS TRIALS COLLABORATION (MSTC)

MSTC aims to provide patients with MS who are not suitable for current therapies, access to pharmaceutical-sponsored clinical trials.  Furthermore, to use generated income by undertaking pharmaceutical clinical trials to devise and administer research-led clinical trials thereby providing greater access to potential treatment to more MS patients.